AARP Will Join Suits Against Drug Makers
AARP, which represents 35 million older Americans, said it will join lawsuits against six drug makers accused of improperly blocking less expensive generic versions of their drugs.
The cases include Bristol-Myers Squibb Co.’s BuSpar anti-anxiety drug, Schering-Plough Corp.’s K-dur potassium chloride supplement and AstraZeneca’s breast cancer treatment tamoxifen.
Prescription Access Litigation Project, a Boston-based coalition of consumer advocates, initially filed the lawsuits.
Bristol-Myers Squibb, AstraZeneca and Schering-Plough officials declined to comment.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
